SAN
DIEGO, Nov. 14, 2022 /PRNewswire/
-- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine
technology innovation, focused on transforming spine surgery with
minimally disruptive, procedurally integrated solutions, today
announced it will continue its partnership with the Cervical Spine
Research Society (CSRS) as a diamond sponsor and will attend the
CSRS 50th Annual Meeting held November 16 to 19 in San Diego.
"The recent launch of our leading posterior cervical fusion
solution, Reline Cervical, and our annual meeting sponsorship of a
preeminent cervical society, CSRS, underscores our shared belief in
further advancing cervical technology," said Chris Barry, chief executive officer at
NuVasive. "We look forward to showcasing our comprehensive,
procedurally integrated C360 portfolio, and its initial step toward
intelligent surgery with full Pulse compatibility."
NuVasive will host two workshops on Thursday, November 17 in room Hillcrest CD.
From 6:30 to 7:15 a.m. PT, a
hands-on workshop, TDR: What are you waiting for? Fantasy
vs. reality, featuring Dr. Ali Mesiwala, DISC Sports and Spine Center, and
Dr. Rory Murphy, Barrow Neurological
Institute. From 11:30 a.m. to 12:30 p.m.
PT, an industry lunch workshop, Approaching
cervicothoracic kyphotic deformities—anterior, posterior and
360, featuring Dr. Praveen
Mummaneni, UCSF Health, Dr. Rick
Sasso, Indiana Spine Hospital, and Dr. Todd Albert, Hospital for Special Surgery.
NuVasive booth #105/204 will feature the Company's full
C360™ portfolio, made up of best-in-class access instrumentation,
implants, biologic materials, and enabling technologies within
Pulse® for the anterior and posterior cervical
spine.
About NuVasive
NuVasive,
Inc. (NASDAQ: NUVA) is the leader in
spine technology innovation, with a mission to transform surgery,
advance care, and change lives. The Company's less-invasive,
procedurally integrated surgical solutions are designed to deliver
reproducible and clinically proven outcomes. The Company's
comprehensive procedural portfolio includes surgical access
instruments, spinal implants, fixation systems, biologics, software
for surgical planning, navigation and imaging solutions,
magnetically adjustable implant systems for spine and orthopedics,
and intraoperative neuromonitoring technology and
service offerings. With more than $1 billion in net
sales, NuVasive operates in more than 50
countries serving surgeons, hospitals, and patients. For more
information, please
visit www.nuvasive.com.
Forward-Looking
Statements
NuVasive cautions you that statements
included in this news release that are not a description of
historical facts are forward-looking statements that involve risks,
uncertainties, assumptions and other factors which, if they do not
materialize or prove correct, could
cause NuVasive's results to differ materially from
historical results or those expressed or implied by such
forward-looking statements. The potential risks and uncertainties
which contribute to the uncertain nature of these statements
include, among others, risks associated with acceptance of the
Company's surgical products and procedures by spine surgeons and
hospitals, development and acceptance of new products or product
enhancements, clinical and statistical verification of the benefits
achieved via the use of NuVasive's products, the
Company's ability to adequately manage inventory as it continues to
release new products, its ability to recruit and retain management
and key personnel, and the other risks and uncertainties described
in NuVasive's news releases and periodic filings with
the Securities and Exchange
Commission. NuVasive's public filings with
the Securities and Exchange Commission are available
at www.sec.gov. NuVasive assumes no obligation to
update any forward-looking statement to reflect events or
circumstances arising after the date on which it was
made.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/nuvasive-to-sponsor-and-participate-at-the-cervical-spine-research-society-50th-annual-meeting-301676684.html
SOURCE NuVasive, Inc.